Conference Call 8:00am ET, Wednesday August 20, 2025 WILMINGTON, Del., Aug. 13, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)...
VANCOUVER, BC, Aug. 13, 2025 /PRNewswire/ - New Found Gold Corp. ("New Found Gold" or the "Company") (TSXV: NFG) (NYSE-A:...
SAN JOSE, Calif.--(BUSINESS WIRE)--Momentus Inc. (NASDAQ: MNTS) ("Momentus" or the "Company"), a leading U.S. commercial space firm specializing in satellite...
Strong Service Growth; Debt Refinancing Complete; Company Issues FY26 Guidance MADISON, Wis., Aug. 13, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY)...
LAS VEGAS--(BUSINESS WIRE)--ALT5 Sigma Corporation (the “Company,” “our” or “ALT5”) (NASDAQ: ALTS) (FRA:5AR1), a fintech specializing in turnkey, crypto-related solutions...
ST. PAUL, Minn., Aug. 13, 2025 /PRNewswire/ -- Solventum Corporation (NYSE: SOLV, "Company" or "Solventum") today announced the launch of a...
ENGLEWOOD, Colo., Aug. 13, 2025 /PRNewswire/ -- Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) ("Red Robin" or the "Company"), a...
First Half 2025 Net Income Available to Common Shareholders Expected to be in the Range of $125.0 Million to $145.0...
Announced positive data from the Phase 1 clinical trial of ELVN-001 in CML, reporting a cumulative MMR rate of 47%...
Company maintains full year 2025 outlook HOUSTON, Aug. 13, 2025 /PRNewswire/ -- Drilling Tools International Corp. (NASDAQ: DTI) ("DTI" or...
Marpai Slashes Losses by Two-Thirds in Q2 2025, Paving the Way to Profitability.Operating Expenses Cut 70% as Turnaround Gains Traction...
Q2 2025 Sales Growth of 134% to $3.0 Million Fueled by Strong Demand for New Products and Technologies Records Two...
Full enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS,...
RENO, Nev., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or the “Company”), a pioneer in...
PALO ALTO, Calif., Aug. 13, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial...
Australian Cancer Trial Advances with First Cohort Complete, Amended Protocol, and Promising Preclinical Data Published; Operating Expenses Cut by 32%...
TORONTO and GLIL YAM, Israel, Aug. 13, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC), a...
BARTLETT, Tenn., Aug. 13, 2025 /PRNewswire/ -- SurgePays, Inc. (Nasdaq: SURG) ("SurgePays" or the "Company"), a wireless and point-of-sale technology...
Dallas, Texas--(Newsfile Corp. - August 13, 2025) - Surf Air Mobility Inc. (NYSE: SRFM): Stonegate Capital Partners updates their coverage...
VIENNA, Va.--(BUSINESS WIRE)--Spire Global, Inc. (NYSE: SPIR) (“Spire” or “the Company”), a global provider of space-based data, analytics and space...
Delivers positive operating income Second quarter 2025 worldwide net sales totaled $220 million Gross margin expanded 490 basis points to...
RICHARDSON, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (NASDAQ: FOSL) (“Fossil” or the “Company”) today announced that...
ProPhase Delivers Significant Operational and Financial Improvements, Advances Multiple Non-Dilutive Liquidity Initiatives, and Targets Transformational Growth Catalysts Company granted key...
TPV at record high of US$9.2 billion, growing more than 50% YoY for the third consecutive quarter.Brazil and Mexico posted...
MONTEVIDEO, Uruguay, Aug. 13, 2025 (GLOBE NEWSWIRE) -- DLocal Limited (“dLocal”, “we”, “us”, and “our”) (NASDAQ:DLO), a technology - first...
ASCO 2025 presentation: First-in-class agent Plinabulin drives immune re-sensitization in NSCLC patients progressed to PD-1/L1 therapiesMed (Cell Press) Publication with MD...
Q2 2025 Revenue up 18%, Driving Solid Gross Margins and ProfitabilityBeginning Production on Integrated Sensing Solution for Division of Top...
Q2 2025 Revenue up 18%, Driving Solid Gross Margins and ProfitabilityBeginning Production on Integrated Sensing Solution for Division of Top...
CAMBRIDGE, Mass., Aug. 13, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...
Topline results from the OV329 Phase 1 safety, tolerability and biomarker study remain on track for a readout in Q3...
Second Quarter Fiscal 2025 versus 2024 1,059 total centers in 44 states was flatSystem-wide sales of $257.6 million decreased 1.0%Total...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Therapeutics, Inc., a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets...
JERSEY CITY, N.J., Aug. 13, 2025 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution...
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio (NASDAQ: IBRX), a leading immunotherapy company, announced today early findings from its QUILT-106 Phase I trial,...
Organizations That Prioritize Technology and Talent Investments Report Significantly Lower Concerns about Managing Risk CHARLESTON, S.C., Aug. 13, 2025 /PRNewswire/...
ORLANDO, Fla., Aug. 13, 2025 /PRNewswire/ -- MCAP Inc. (OTC: MCAP), a financial technology and securities market making company, today...
Cash of $6.1 million as of June 30, 2025, with cash provided by operations of $0.7 million in Q2 2025,...
$50 Million Raise at $10/Share Positions Thumzup for Aggressive Crypto Portfolio Growth and Mining BuildoutThe Company is Authorized to Allocate...
RIO DE JANEIRO, Aug. 13, 2025 /PRNewswire/ -- Vinci Compass Investments Ltd. (NASDAQ: VINP) ("Vinci Compass," "the Company," "we," "us,"...
PHOENIX, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company focused on...
